Annual EBIT
-$33.22 M
+$1.36 M+3.92%
December 31, 2023
Summary
- As of February 25, 2025, TCRT annual earnings before interest & taxes is -$33.22 million, with the most recent change of +$1.36 million (+3.92%) on December 31, 2023.
- During the last 3 years, TCRT annual EBIT has risen by +$46.76 million (+58.46%).
- TCRT annual EBIT is now -83155.64% below its all-time high of -$39.90 thousand, reached on December 31, 2002.
Performance
TCRT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.13 M
+$2000.00+0.18%
September 30, 2024
Summary
- As of February 25, 2025, TCRT quarterly earnings before interest & taxes is -$1.13 million, with the most recent change of +$2000.00 (+0.18%) on September 30, 2024.
- Over the past year, TCRT quarterly EBIT has increased by +$2000.00 (+0.18%).
- TCRT quarterly EBIT is now -24944.44% below its all-time high of -$4500.00, reached on September 30, 2000.
Performance
TCRT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$11.78 M
+$7.35 M+38.42%
September 30, 2024
Summary
- As of February 25, 2025, TCRT TTM earnings before interest & taxes is -$11.78 million, with the most recent change of +$7.35 million (+38.42%) on September 30, 2024.
- Over the past year, TCRT TTM EBIT has increased by +$7.35 million (+38.42%).
- TCRT TTM EBIT is now -40384.54% below its all-time high of -$29.10 thousand, reached on June 30, 2000.
Performance
TCRT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TCRT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | +0.2% | +38.4% |
| 3 y3 years | +58.5% | +94.9% | +86.8% |
| 5 y5 years | +38.4% | +94.5% | +84.0% |
TCRT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.2% | at high | +89.8% | at high | +84.8% |
| 5 y | 5-year | at high | +58.5% | at high | +95.0% | at high | +86.8% |
| alltime | all time | <-9999.0% | +79.9% | <-9999.0% | +99.1% | <-9999.0% | +93.1% |
Alaunos Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.13 M(-0.2%) | -$11.78 M(-38.4%) |
| Jun 2024 | - | -$1.13 M(-32.9%) | -$19.13 M(-25.6%) |
| Mar 2024 | - | -$1.68 M(-78.6%) | -$25.71 M(-22.6%) |
| Dec 2023 | -$33.22 M(-3.9%) | -$7.84 M(-7.5%) | -$33.22 M(-1.3%) |
| Sep 2023 | - | -$8.48 M(+10.0%) | -$33.65 M(+1.4%) |
| Jun 2023 | - | -$7.71 M(-16.2%) | -$33.18 M(-4.3%) |
| Mar 2023 | - | -$9.20 M(+11.2%) | -$34.67 M(+0.3%) |
| Dec 2022 | -$34.58 M(-55.4%) | -$8.27 M(+3.3%) | -$34.58 M(-7.4%) |
| Sep 2022 | - | -$8.01 M(-12.9%) | -$37.36 M(-27.7%) |
| Jun 2022 | - | -$9.19 M(+1.0%) | -$51.63 M(-20.7%) |
| Mar 2022 | - | -$9.11 M(-17.6%) | -$65.11 M(-16.1%) |
| Dec 2021 | -$77.56 M(-3.0%) | -$11.05 M(-50.4%) | -$77.56 M(-12.8%) |
| Sep 2021 | - | -$22.29 M(-1.7%) | -$88.90 M(+2.3%) |
| Jun 2021 | - | -$22.67 M(+5.2%) | -$86.93 M(+4.9%) |
| Mar 2021 | - | -$21.55 M(-3.7%) | -$82.87 M(+3.6%) |
| Dec 2020 | -$79.98 M(+38.2%) | -$22.39 M(+10.2%) | -$79.98 M(+8.6%) |
| Sep 2020 | - | -$20.32 M(+9.2%) | -$73.62 M(+10.3%) |
| Jun 2020 | - | -$18.61 M(-0.3%) | -$66.75 M(+6.1%) |
| Mar 2020 | - | -$18.66 M(+16.4%) | -$62.90 M(+8.7%) |
| Dec 2019 | -$57.86 M(+7.3%) | -$16.04 M(+19.2%) | -$57.86 M(+6.0%) |
| Sep 2019 | - | -$13.45 M(-8.8%) | -$54.58 M(+1.6%) |
| Jun 2019 | - | -$14.75 M(+8.3%) | -$53.71 M(+4.6%) |
| Mar 2019 | - | -$13.62 M(+6.7%) | -$51.33 M(-4.8%) |
| Dec 2018 | -$53.91 M(+0.8%) | -$12.76 M(+1.5%) | -$53.91 M(-1.2%) |
| Sep 2018 | - | -$12.57 M(+1.6%) | -$54.58 M(-0.9%) |
| Jun 2018 | - | -$12.38 M(-23.6%) | -$55.09 M(-1.1%) |
| Mar 2018 | - | -$16.20 M(+20.5%) | -$55.72 M(+4.2%) |
| Dec 2017 | -$53.49 M(-67.6%) | -$13.44 M(+2.7%) | -$53.49 M(+4.5%) |
| Sep 2017 | - | -$13.08 M(+0.5%) | -$51.17 M(+4.4%) |
| Jun 2017 | - | -$13.01 M(-6.8%) | -$49.00 M(-70.7%) |
| Mar 2017 | - | -$13.96 M(+25.7%) | -$167.23 M(+1.2%) |
| Dec 2016 | -$165.31 M(+37.6%) | -$11.11 M(+1.8%) | -$165.31 M(+1.0%) |
| Sep 2016 | - | -$10.91 M(-91.7%) | -$163.68 M(-4.2%) |
| Jun 2016 | - | -$131.24 M(+990.0%) | -$170.93 M(+217.0%) |
| Mar 2016 | - | -$12.04 M(+27.0%) | -$53.91 M(-55.1%) |
| Dec 2015 | -$120.10 M(+176.1%) | -$9.48 M(-47.8%) | -$120.10 M(-0.9%) |
| Sep 2015 | - | -$18.17 M(+27.7%) | -$121.21 M(+5.4%) |
| Jun 2015 | - | -$14.22 M(-81.8%) | -$114.99 M(+2.7%) |
| Mar 2015 | - | -$78.23 M(+638.3%) | -$111.94 M(+157.3%) |
| Dec 2014 | -$43.50 M(-24.6%) | -$10.60 M(-11.3%) | -$43.50 M(+9.8%) |
| Sep 2014 | - | -$11.94 M(+6.8%) | -$39.62 M(+7.7%) |
| Jun 2014 | - | -$11.18 M(+14.2%) | -$36.80 M(-16.2%) |
| Mar 2014 | - | -$9.78 M(+45.6%) | -$43.92 M(-23.9%) |
| Dec 2013 | -$57.71 M(-43.5%) | -$6.72 M(-26.3%) | -$57.72 M(-35.8%) |
| Sep 2013 | - | -$9.12 M(-50.2%) | -$89.84 M(-12.3%) |
| Jun 2013 | - | -$18.30 M(-22.4%) | -$102.45 M(-4.4%) |
| Mar 2013 | - | -$23.58 M(-39.3%) | -$107.12 M(+4.8%) |
| Dec 2012 | -$102.17 M | -$38.84 M(+78.8%) | -$102.17 M(+28.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$21.73 M(-5.4%) | -$79.74 M(+10.4%) |
| Jun 2012 | - | -$22.97 M(+23.3%) | -$72.22 M(+16.3%) |
| Mar 2012 | - | -$18.63 M(+13.5%) | -$62.11 M(-13.0%) |
| Dec 2011 | -$71.40 M(+190.9%) | -$16.42 M(+15.5%) | -$71.40 M(+16.4%) |
| Sep 2011 | - | -$14.21 M(+10.6%) | -$61.34 M(+10.3%) |
| Jun 2011 | - | -$12.85 M(-54.0%) | -$55.63 M(+16.1%) |
| Mar 2011 | - | -$27.93 M(+339.0%) | -$47.90 M(+95.2%) |
| Dec 2010 | -$24.55 M(+102.5%) | -$6.36 M(-25.2%) | -$24.55 M(+10.5%) |
| Sep 2010 | - | -$8.50 M(+66.1%) | -$22.21 M(+36.4%) |
| Jun 2010 | - | -$5.12 M(+12.0%) | -$16.28 M(+21.9%) |
| Mar 2010 | - | -$4.57 M(+13.4%) | -$13.36 M(+10.2%) |
| Dec 2009 | -$12.12 M(-52.7%) | -$4.03 M(+56.8%) | -$12.12 M(-4.2%) |
| Sep 2009 | - | -$2.57 M(+17.2%) | -$12.66 M(-19.4%) |
| Jun 2009 | - | -$2.19 M(-34.2%) | -$15.71 M(-22.0%) |
| Mar 2009 | - | -$3.33 M(-27.0%) | -$20.13 M(-21.4%) |
| Dec 2008 | -$25.62 M(-10.3%) | -$4.56 M(-18.8%) | -$25.62 M(-12.1%) |
| Sep 2008 | - | -$5.62 M(-15.1%) | -$29.15 M(-7.1%) |
| Jun 2008 | - | -$6.62 M(-25.0%) | -$31.39 M(-1.8%) |
| Mar 2008 | - | -$8.82 M(+8.9%) | -$31.97 M(+11.9%) |
| Dec 2007 | -$28.57 M(+49.5%) | -$8.10 M(+3.0%) | -$28.57 M(+7.0%) |
| Sep 2007 | - | -$7.86 M(+9.3%) | -$26.69 M(+17.3%) |
| Jun 2007 | - | -$7.20 M(+32.8%) | -$22.76 M(+7.1%) |
| Mar 2007 | - | -$5.42 M(-12.9%) | -$21.26 M(+11.2%) |
| Dec 2006 | -$19.11 M(+95.3%) | -$6.22 M(+58.3%) | -$19.11 M(+23.7%) |
| Sep 2006 | - | -$3.93 M(-30.9%) | -$15.45 M(+7.4%) |
| Jun 2006 | - | -$5.69 M(+73.8%) | -$14.38 M(+33.2%) |
| Mar 2006 | - | -$3.27 M(+28.2%) | -$10.80 M(+10.3%) |
| Dec 2005 | -$9.79 M(+71.5%) | -$2.55 M(-10.7%) | -$9.79 M(-0.8%) |
| Sep 2005 | - | -$2.86 M(+35.6%) | -$9.87 M(+18.0%) |
| Jun 2005 | - | -$2.11 M(-6.9%) | -$8.36 M(+33.4%) |
| Mar 2005 | - | -$2.26 M(-14.1%) | -$6.27 M(+56.3%) |
| Dec 2004 | -$5.71 M(+3454.5%) | -$2.64 M(+94.8%) | -$4.01 M(+165.4%) |
| Sep 2004 | - | -$1.35 M(+8255.6%) | -$1.51 M(+805.9%) |
| Jun 2004 | - | -$16.20 K(+145.5%) | -$166.90 K(+6.1%) |
| Mar 2004 | - | -$6600.00(-95.1%) | -$157.30 K(-2.1%) |
| Dec 2003 | -$160.60 K(+302.5%) | -$135.60 K(+1495.3%) | -$160.60 K(+348.6%) |
| Sep 2003 | - | -$8500.00(+28.8%) | -$35.80 K(+5.6%) |
| Jun 2003 | - | -$6600.00(-33.3%) | -$33.90 K(-16.7%) |
| Mar 2003 | - | -$9900.00(-8.3%) | -$40.70 K(+1.8%) |
| Dec 2002 | -$39.90 K(-45.0%) | -$10.80 K(+63.6%) | -$40.00 K(-42.5%) |
| Sep 2002 | - | -$6600.00(-50.7%) | -$69.60 K(-0.4%) |
| Jun 2002 | - | -$13.40 K(+45.7%) | -$69.90 K(+2.3%) |
| Mar 2002 | - | -$9200.00(-77.2%) | -$68.30 K(-5.8%) |
| Dec 2001 | -$72.50 K | -$40.40 K(+485.5%) | -$72.50 K(+125.9%) |
| Sep 2001 | - | -$6900.00(-41.5%) | -$32.10 K(+8.1%) |
| Jun 2001 | - | -$11.80 K(-11.9%) | -$29.70 K(-36.8%) |
| Mar 2001 | - | -$13.40 K(+197.8%) | -$47.00 K(+39.9%) |
| Sep 2000 | - | -$4500.00(-84.5%) | -$33.60 K(+15.5%) |
| Jun 2000 | - | -$29.10 K | -$29.10 K |
FAQ
- What is Alaunos Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual EBIT year-on-year change?
- What is Alaunos Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly EBIT year-on-year change?
- What is Alaunos Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Alaunos Therapeutics?
- What is Alaunos Therapeutics TTM EBIT year-on-year change?
What is Alaunos Therapeutics annual earnings before interest & taxes?
The current annual EBIT of TCRT is -$33.22 M
What is the all time high annual EBIT for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual earnings before interest & taxes is -$39.90 K
What is Alaunos Therapeutics annual EBIT year-on-year change?
Over the past year, TCRT annual earnings before interest & taxes has changed by +$1.36 M (+3.92%)
What is Alaunos Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of TCRT is -$1.13 M
What is the all time high quarterly EBIT for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly earnings before interest & taxes is -$4500.00
What is Alaunos Therapeutics quarterly EBIT year-on-year change?
Over the past year, TCRT quarterly earnings before interest & taxes has changed by +$2000.00 (+0.18%)
What is Alaunos Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of TCRT is -$11.78 M
What is the all time high TTM EBIT for Alaunos Therapeutics?
Alaunos Therapeutics all-time high TTM earnings before interest & taxes is -$29.10 K
What is Alaunos Therapeutics TTM EBIT year-on-year change?
Over the past year, TCRT TTM earnings before interest & taxes has changed by +$7.35 M (+38.42%)